AOD-9604 5 MG

Description

DESCRIPTION

AOD-9604 is a synthetic peptide fragment corresponding to amino acids 177–191 of human growth hormone, modified to remove growth-promoting activity while retaining the C-terminal lipolytic region. It is studied in research models for adipocyte signaling activity.

RESEARCH AREAS

• Lipolytic pathway activity — studied in adipocyte cell culture for lipid metabolism signaling.
• Non-mitogenic profile — research has characterized its lack of IGF-1 axis activation, distinguishing it from full-length GH.
• Cartilage research — investigated for chondrocyte activity in preclinical joint repair models.
• Comparative fragment research — characterized alongside full-length GH in receptor and pathway studies.

WHAT RESEARCHERS LOOK AT

• Mechanism: C-terminal GH fragment with selective lipolytic signaling.
• Absence of IGF-1 and somatogenic receptor activation.
• In vitro adipocyte response studies.
• Applications in chondrocyte and cartilage research models.

QUICK SPECS

• Form: Lyophilized peptide
• Net per vial: 5 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

IDENTITY BASICS

• Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
• Formula / M.W.: C78H123N23O23S2, ~1815 g/mol
• CAS: 221231-10-3

SELECTED RESEARCH

• PubChem entry — chemical identity:
  
  https://pubchem.ncbi.nlm.nih.gov/compound/71300964
  
• Adipocyte and lipid pathway research:
  
  https://pubmed.ncbi.nlm.nih.gov/18301732/
  
• Chondrocyte and cartilage research:
  
  https://pubmed.ncbi.nlm.nih.gov/24127299/
  

DISCLAIMER

• This product is intended for laboratory research use only.

• Not for human or veterinary use.

• Not approved for diagnostic, therapeutic, or medical applications.

• Handle using appropriate laboratory safety procedures and personal protective equipment.